List of articles with "MetaVia"

MetaVia's Vanoglipel Data

MetaVia's Vanoglipel Data

United States Washington D.C. MetaVia Vanoglipel Phase 2a Data
MetaVia's DA-1726 Results

MetaVia's DA-1726 Results

United States Atlanta MetaVia DA-1726 ObesityWeek
MetaVia's AASLD 2025 Update

MetaVia's AASLD 2025 Update

United States Washington, D.C. MetaVia GPR119 Vanoglipel
MetaVia's DA-1726 Research

MetaVia's DA-1726 Research

USA Atlanta MetaVia DA-1726 ObesityWeek
MetaVia's Upcoming Conferences

MetaVia's Upcoming Conferences

United States Boston MetaVia DA-1726 OXM
MetaVia Q2 2025 Update

MetaVia Q2 2025 Update

USA Cambridge MetaVia DA-1241 DA-1726
MetaVia DA-1726 Trial

MetaVia DA-1726 Trial

USA Cambridge MetaVia DA-1726 obesity research
MetaVia & Syntekabio AI

MetaVia & Syntekabio AI

United States Cambridge MetaVia DA-1241 Syntekabio
MetaVia Phase 1 Trial

MetaVia Phase 1 Trial

United States Cambridge MetaVia Obesity Treatment DA-1726
Promising MASH Results

Promising MASH Results

USA Chicago MetaVia DA-1241 Efruxifermin
DA-1241 Research Presentation

DA-1241 Research Presentation

USA Chicago MetaVia DA-1241 GPR119
MetaVia Q1 2025 Results

MetaVia Q1 2025 Results

United States Cambridge MetaVia DA-1241 DA-1726
MetaVia Private Placement

MetaVia Private Placement

United States Cambridge MetaVia DA-1726 cardiometabolic diseases
MetaVia's DA-1241 Data

MetaVia's DA-1241 Data

United States Cambridge MetaVia DA-1241 GPR119
MetaVia's DA-1241 Presentation

MetaVia's DA-1241 Presentation

USA Cambridge MetaVia DA-1241 EASL Congress
MetaVia DA-1726 Results

MetaVia DA-1726 Results

USA Cambridge MetaVia Obesity Treatment DA-1726
DA-1726 Clinical Trial Insights

DA-1726 Clinical Trial Insights

USA Cambridge MetaVia Obesity Treatment DA-1726
MetaVia's 2024 Results

MetaVia's 2024 Results

USA Cambridge MetaVia DA-1241 DA-1726
DA-1241 Phase 2a Results

DA-1241 Phase 2a Results

USA Cambridge MASH MetaVia DA-1241

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.